Does Low Cholesterol Equal Lower Risk of High-Grade Prostate Cancer?
Date: November 11, 2010
Cancer Epidemiology, Biomarkers & Prevention, November 3, 2009
We knew that low cholesterol was good for the heart, but until recently, we didn’t know it was good for the prostate. A study of more than 5,000 U.S. men revealed evidence that men with lower cholesterol are less likely than those with higher levels to develop the most aggressive type of prostate cancer.
The findings came from a collaborative study led by Elizabeth A. Platz, Sc.D., M.P.H., co- director of the cancer prevention and control program at the Kimmel Cancer Center. Platz and collaborators from the Southwest Oncology Group looked back at 5,586 men, 55 and older, who participated in the Prostate Cancer Prevention trial from 1993-1996. More than 1200 of the men were diagnosed with prostate cancer during the study, and the researchers set out to find differences between those who developed prostate cancer and those who did not.
They found that men with cholesterol levels, at or below the normal range, slashed their risk of developing more aggressive high-grade, prostate cancer by nearly 60 percent. Cholesterol levels did not seem to impact the whole spectrum of prostate cancer incidence, but rather only this more aggressive form of the disease, a type more likely to grow and spread rapidly.
"Cholesterol may affect cancer cells at a level where it influences key signaling pathways controlling cell survival," says Platz. "Cancer cells use these survival pathways to evade the normal cycle of cell life and death."
Platz cautions that, while the group took into account factors that could bias the results, such as smoking history, weight, and family history of prostate cancer, other things could have affected their results. One example is whether men in the study were taking cholesterol-lowering drugs at the time of the blood collections, a data point the researchers expect to analyze soon.
This is not the first time Platz has observed a connection between cholesterol and prostate cancer. Her studies published in collaboration with Harvard investigators in 2006 and 2008 linked the use of statins, a type of cholesterol-lowering drug and low cholesterol to a decreased risk of developing aggressive prostate cancer.
While additional research is needed to know for sure, Platz says that targeting cholesterol metabolism may be one route to preventing and treating prostate cancer.
Funding for the study was provided by the National Cancer Institute.
Articles in this Issue
Cover Story: Personalized Medicine is Here, The Time is Now
- Personalized Medicine is Here: The Time is Now
- Cover Story Sidebar: Our Cancer Reasearch is Curing Other Diseases Too
- Cover Story Sidebar: A New Paradigm for Cancer Drug Discovery
- Cover Story Sidebar: Personalized Approaches in Pediatric Cancer
- Cover Story Sidebar: The Frankenstein Project
- Cover Story Sidebar: The Serendipitous Discovery of a Cancer Starter
- Cover Story Sidebar: The Mathematics of Curing Cancer
- Immune Cell Commander
- A Personalized Genetic Profile for Brain Cancer
- A New "Twist" in Breast Cancer
- JHU Engineering Student Invents Melanoma Screening Device
- Special Delivery: Biodegradable Particles Transport Drugs to Diseased Tissues and Organs
- Targeting Brain Cancer Stem Cells
- Vaccine Clears Out Leukemia Cells
- Does Low Cholesterol Equal Lower Risk of High-Grade Prostate Cancer?
- A Common Good - The Commonwealth Foundation
- Helping Us Solve The Cancer Puzzle
- The Skip Viragh Center
- Making Waves to Fight Cancer
- Gift Brings Complementary Care to Cancer Patients
- A Major Gift for Kidney Cancer Research
- Giant Food Supports Childhood Cancer Research
- Wawa Cares About Cancer Patients
- Young Lacrosse Players Faced Off Against Childhood Cancer